This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Mark Your Calendar for Next Year's Event!
May 9-12, 2022Hynes Convention Center, Boston

Philipp Wenter, Ph.D.
Senior Director of Drug Substance Manufacturing, Technical Operations at Apellis Pharmaceuticals


Dr. Philipp Wenter is Senior Director of Drug Substance Manufacturing at Apellis Pharmaceuticals. Before that Dr. Wenter held the position of VP of Manufacturing at Eurofins Genomics and Director of Process Development and R&D at Operon Biotechnologies. He has extensive experience in developing and optimizing manufacturing processes for automated synthesis and purification of large synthetic biomolecules.

Dr. Wenter obtained his diploma in Chemistry in 2001 and a PhD in the field of Bioorganic Synthesis form the EPFL in Lausanne in 2006.

Agenda Sessions

  • ROOM 205B: Pegcetacoplan – Towards the Implementation of an Efficient Manufacturing Process for a PEG-ylated Peptide at an Industrial Scale, and the Associated Strategy for a Regulatory Approval